中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
24期
49-50,53
,共3页
克林霉素%用药安全%不良反应
剋林黴素%用藥安全%不良反應
극림매소%용약안전%불량반응
Clindamycin%Medication safety%Adverse reactions
目的:研究分析克林霉素用药的不良反应特点以及用药的安全性情况。方法选择该院从2012年10月—2013年10月收治的120例使用克林霉素后出现不良反应的患者,对所有患者的临床资料进行回顾性分析,对克林霉素的用药情况进行综合分析和研究。根据克林霉素引发的不良反应涉及的器官和系统,对不同患者的具体病情进行相应的处理措施。结果在所有不良反应中,过敏反应的发生率最高,达到34.17%,最低为泌尿系统,为5.00%,差异有统计学意义(P<0.05)。在给药途径中因为静脉滴注而导致不良反应的患者有93例,发生率为77.5%。与其他给药途径发生率的差异有统计学意义(P<0.01)。联合使用甲硝唑与环丙沙星的用药引发不良反应的患者比较明显,均为3例,占患者数的18.75%,而其他联合用药主要引发轻微的皮肤和胃肠道反应。结论医护人员在临床工作过程中需要对于克林霉素的合理运用加用足够的关注,并且做好相应的防护工作,尽量降低克林霉素的不良反应发生率,提高临床用药的安全性。
目的:研究分析剋林黴素用藥的不良反應特點以及用藥的安全性情況。方法選擇該院從2012年10月—2013年10月收治的120例使用剋林黴素後齣現不良反應的患者,對所有患者的臨床資料進行迴顧性分析,對剋林黴素的用藥情況進行綜閤分析和研究。根據剋林黴素引髮的不良反應涉及的器官和繫統,對不同患者的具體病情進行相應的處理措施。結果在所有不良反應中,過敏反應的髮生率最高,達到34.17%,最低為泌尿繫統,為5.00%,差異有統計學意義(P<0.05)。在給藥途徑中因為靜脈滴註而導緻不良反應的患者有93例,髮生率為77.5%。與其他給藥途徑髮生率的差異有統計學意義(P<0.01)。聯閤使用甲硝唑與環丙沙星的用藥引髮不良反應的患者比較明顯,均為3例,佔患者數的18.75%,而其他聯閤用藥主要引髮輕微的皮膚和胃腸道反應。結論醫護人員在臨床工作過程中需要對于剋林黴素的閤理運用加用足夠的關註,併且做好相應的防護工作,儘量降低剋林黴素的不良反應髮生率,提高臨床用藥的安全性。
목적:연구분석극림매소용약적불량반응특점이급용약적안전성정황。방법선택해원종2012년10월—2013년10월수치적120례사용극림매소후출현불량반응적환자,대소유환자적림상자료진행회고성분석,대극림매소적용약정황진행종합분석화연구。근거극림매소인발적불량반응섭급적기관화계통,대불동환자적구체병정진행상응적처리조시。결과재소유불량반응중,과민반응적발생솔최고,체도34.17%,최저위비뇨계통,위5.00%,차이유통계학의의(P<0.05)。재급약도경중인위정맥적주이도치불량반응적환자유93례,발생솔위77.5%。여기타급약도경발생솔적차이유통계학의의(P<0.01)。연합사용갑초서여배병사성적용약인발불량반응적환자비교명현,균위3례,점환자수적18.75%,이기타연합용약주요인발경미적피부화위장도반응。결론의호인원재림상공작과정중수요대우극림매소적합리운용가용족구적관주,병차주호상응적방호공작,진량강저극림매소적불량반응발생솔,제고림상용약적안전성。
Objective To analyze the characteristics of adverse reactions of clindamycin and the safety of the drug. Methods 120 cases with adverse reactions after using clindamycin admitted in our hospital from October 2012 to October 2013 were selected. The clinical data of all the patients were analyzed retrospectively; the use of clindamycin was analyzed and studied comprehensively. The specific condition of the patients was treated correspondingly according to the organs and systems involved by the adverse reactions of clindamycin. Results Of all the adverse reactions, the incidence of allergic reaction is the highest, reaches 34.17%, the lowest is the incidence of urinary system, which is 5.00%, the difference is significant (P<0.05). Of the routes of administration, 93 cases with the adverse reactions due to intravenous drip, the incidence is 77.5%, the difference in the incidence of adverse reactions caused by intravenous drip and other routes of administration is statistically significant ( P<0.01). Adverse reactions caused by combined with metronidazole and ciprofloxacin drugs in patients is more noticeable, are all 3 cases, accounting for 18.75% of the number of patients, while other combination mainly cause slight skin and gastrointestinal reaction. Conclusion Medical staff should pay enough attention to the reasonable use of clindamycin in clinical work, and do a good job in the corresponding protection so as to reduce the incidence of adverse reactions of clindamycin and improve the safety of clinical medication.